SCHEMBL9594446

SCHEMBL9594446

COc1ccc2nc3cc(OC)c(OC)cc3c(Nc3ccc(CO)cc3)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.54
▸ PHLPP2 Q6ZVD8 2/20 0.53
▸ KDM1A O60341 4/20 0.53
▸ POLB P06746 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ RAD52 P43351 2/20 0.49
▸ GFER P55789 1/20 0.49
▸ CSF1R P07333 1/20 0.48
▸ MAPT P10636 3/20 0.48
▸ TP53 P04637 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ MAP2K1 Q02750 2/20 0.47
▸ TERT O14746 1/20 0.46
▸ CYP19A1 P11511 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ EGFR P00533 1/20 0.44
▸ LCK P06239 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9592698 0.93 KDM1A (0.53) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9594191 0.93 KDM1A (0.59) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9594286 0.92 HDAC1 (0.52) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9594422 0.92 HDAC1 (0.52) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9593647 0.92 KDM1A (0.50) KDM1APOLBCSF1RMAPTTP53
SCHEMBL9594305 0.91 PHLPP2 (0.61) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9594824 0.88 SLC2A1 (0.48) HDAC1HDAC6KDM1AKMT2AMAP2K1
SCHEMBL9595381 0.88 HDAC1 (0.54) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9595086 0.88 TOP2A (0.58) HDAC1HDAC6PHLPP2KDM1APOLB
SCHEMBL9594504 0.87 KDM1A (0.69) HDAC1HDAC6PHLPP2KDM1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 — — US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO disclosed
Send feedback